The global mRNA therapeutics and mRNA vaccine market is
witnessing steady growth, estimated to be worth USD 51.3 billion in 2023.
In recent years, the mRNA vaccine and
therapeutics markethas grown significantly,
driven by increasing demand for targeted therapies to treat diseases that are
difficult to address with conventional drugs. Messenger RNA (mRNA), a
single-stranded ribonucleic acid that encodes proteins, has emerged as a
revolutionary drug class for managing infectious, chronic, and oncological
disorders. Pharmaceut...
more